GGrantIndex
Sort

53,477 grants matching addiction

Isoflavone Treatment for Alcohol Abuse

$548,247
Scott E Lukas · Mclean Hospital · R01 · FY2008 · AA

Administrative Core

$548,241
Horace H Loh · University Of Minnesota · P50 · FY2009 · DA

Deterrents for prescription opioid abuse

$548,214
Kevin B. Freeman · University Of Mississippi Med Ctr · R01 · FY2023 · DA

Sex Differences in Risk for Alcohol Use Disorder: Neural and Hormonal Influences

$548,192
Jessica J Weafer · University Of Kentucky · R01 · FY2021 · AA

Development of a Prospective Memory Intervention to Reduce Drug Use and HIV Risk

$548,172
Matthew Wayne Johnson · Johns Hopkins University · R01 · FY2013 · DA

Genetic pathways for impulsivity and drug reinforcement: DNA and transcriptome variation in mice

$548,085
Desmond James Smith · University Of California Los Angeles · U01 · FY2021 · DA

Factors in Drug Dependence

$548,083
Johns Hopkins University · R01 · FY2003 · DA

Multi-media Adolescent Alcohol &Drug Prevention

$548,066
Inflexxion, Inc. · R44 · FY2003 · DA

Jail-Based Treatment to Reduce Substance Abuse, Recidivism and Risky Behavior

$548,058
June P Tangney · George Mason University · R01 · FY2014 · DA

PURITY SPECIFICATIONS, STORAGE, AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT CONTRACT

$548,027
Katie Hayes · Research Triangle Institute · N01 · FY2022 · DA

A Randomized Trial of Continued Methadone Maintenance vs. Detoxification in Jail

$548,013
Josiah D Rich · Miriam Hospital · R01 · FY2011 · DA

Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving: A Neurobehavioral Investigation

$547,912
Michael Andrew Sayette · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AT

Buprenorphine for Prisoners

$547,897
Timothy W Kinlock · Friends Research Institute, Inc. · R01 · FY2009 · DA

Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV Transmission

$547,877
Julia B Dickson-Gomez · Medical College Of Wisconsin · R01 · FY2021 · DA

Drug Abuse Training Program

$547,801
Jacqueline F. McGinty · Medical University Of South Carolina · T32 · FY2016 · DA

Impact of Prescription Opioid Dose Changes on Cannabis Use and Clinical Outcomes

$547,764
Benjamin J. Morasco · Oregon Health & Science University · R01 · FY2020 · DA

Circadian and sleep mechanisms among racial groups for nicotine dependence, craving, and withdrawal

$547,692
Karen L Cropsey · University Of Alabama At Birmingham · R01 · FY2021 · DA

Preclinical Evaluation of Medications to Treat Polydrug Addiction

$547,592
Nancy K. Mello · Mclean Hospital · R01 · FY2012 · DA

Designing group specific PET ligands for mGluR2

$547,585
Anna-Liisa Brownell · Massachusetts General Hospital · R01 · FY2018 · EB

Psychology of Alcohol and Addiction Training

$547,530
Denis M McCarthy · University Of Missouri-Columbia · T32 · FY2025 · AA

Brain Acetate and Ethanol Metabolism in Alcohol Dependence and Abuse

$547,522
Graeme F Mason · Yale University · R01 · FY2016 · AA

Psychology Training in Alcohol Research (PTAR)

$547,511
Mary E Larimer · University Of Washington · T32 · FY2023 · AA

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

$547,502
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2022 · DA

Implementing Opioid Risk Reduction Strategies into Primary Care Practice

$547,501
Karen Elizabeth Lasser · Boston Medical Center · R01 · FY2012 · DA

Psychosocial and neurobiological stress and opioid use trajectories following pregnancy

$547,496
Helena Jv Rutherford · Yale University · R01 · FY2022 · DA